CLINICAL LAB SERVICES
  •
    Cat #: PLEASE INQUIRE - T-cell MRD Clonality Assay

    T-Cell MRD Clonality Assay

    Combinations of chemotherapy, radiation therapy and bone marrow transplantation are potentially curative for several hematologic malignancies.  Howev...

    View Product
  • Cat #: AVAILABLE IN LATE 2021

    MyMRD® Myeloid Gene Panel Assay

    After genomic DNA is extracted, indexed whole genome libraries will be hybridized with probes targeting mutation hotspots for next-generation duplex s...

    View Product
  • Cat #: MyMRD

    MyMRD® Gene Panel Assay

    Minimal residual disease (MRD) detection has proven to be useful in the clinical management of patients with leukemia and can facilitate the developme...

    View Product
  • Cat #: MyAML

    MyAML® Gene Panel Assay

    Understanding the clonal architecture of AML is vital for successful treatment of patients.1  The same clinical picture may be produced by many diffe...

    View Product
  • Cat #: FLT3-CDx

    LeukoStrat® CDx FLT3 Mutation Assay

    The fms related tyrosine kinase 3 (FLT3) is one of the most commonly mutated genes in acute myeloid leukemia (AML), occurring in approximately 30% o...

    View Product
  • Cat #: HEMATOLYMPHOID SCREENING PANEL

    Hematolymphoid Screening Panel Multiparametric Flow Cytometry

    Biomarkers in the Screening Panel CD2, CD3, CD4, CD5, CD7, CD8, CD10, CD11b, CD13, CD14, CD15, CD16, CD19, CD20, CD23, CD33, CD34, CD38, CD45, CD56, C...

    View Product
  • Cat #: B-CELL MRD CLONALITY ASSAY - AVAILABLE IN LATE 2021

    B-Cell MRD Clonality Assay

    Combinations of chemotherapy, radiation therapy and bone marrow transplantation are potentially curative for several hematologic malignancies.  Howev...

    View Product
  • Cat #: AML-MRD-MFC

    AML MRD Assay Multiparametric Flow Cytometry

    Biomarkers in the AML MRD Assay CD2, CD4, CD5, CD7, CD11b, CD13, CD14, CD15, CD16, CD19, CD33, CD34, CD36, CD38, CD45, CD 56, CD64, CD117, CD123, HLAD...

    View Product
  • Cat #: NPM1 MRD

    AML – NPM1 MRD Assay

    Minimal residual disease (MRD) detection by Next-Generation Sequencing has demonstrated utility in predicting clinical outcomes and in generating clin...

    View Product
  • Cat #: FLT3 ITD MRD

    AML – FLT3 ITD MRD Assay

    Minimal residual disease (MRD) detection in patients with leukemia has proven to be useful in the clinical management of disease and can facilitate th...

    View Product
  • Cat #: TRG Clonality

    TRG Clonality Assay

    The human T-Cell Receptor Gamma (TRG) locus on chromosome 7 (7q14) includes 14 variable (Vγ) genes (Group I, II, III, and IV), 5 joining (Jγ) gene s...

    View Product
  • Cat #: TRB-Clonality-Assay

    TRB Clonality Assay

    The human T-cell receptor beta (TRB) gene locus on chromosome 7 (7q34) includes 64-67 variable (Vß) gene segments (belonging to 30 subgroups), 2 dive...

    View Product
  • Cat #: NPM1

    NPM1 Mutation Assay

    The Nucleophosmin (NPM1) gene is one of the most commonly mutated genes in acute myeloid leukemia (AML), occurring in about 35% of AML patients at dia...

    View Product
  • Cat #: IGK Clonality

    IGK Clonality Assay

    During development of lymphoid cells, antigen receptor genes undergo somatic gene rearrangements.1 The human immunoglobulin kappa (IGK) locus on chrom...

    View Product
  • Cat #: IGH-Somatic-Hypermutation-Assay

    IGH Somatic Hypermutation Assay

    Lymphoid cells are different from the other somatic cells in the body as during development, the antigen receptor genes in these cells undergo somatic...

    View Product
  • Cat #: IGH Clonality

    IGH Clonality Assays

    Lymphoid cells are different from the other somatic cells in the body as during development, the antigen receptor genes of these cells undergo somatic...

    View Product